-
2022-502890-40-00
5
2024-01-04
Destruction of kidney stones
-
2022-502597-16-00
9
2023-10-27
Intermediate or High-risk Primary or Secondary
Myelofibrosis
-
2022-501057-36-00
5
2023-10-24
ANCA-associated vasculitis
-
2024-513101-31-00
5
2023-09-11
General anaesthetic for outpatient surgery
-
2022-500933-10-00
11
2023-08-02
Preeclampsia during pregnancy
-
2024-514952-34-00
5
2023-06-23
Catheter related bloodstream infections due to Staphylococcus aureus
-
2022-501710-62-02
6
2023-06-07
Peripheral T-cell lymphoma (PTCL)
-
2022-500218-25-01
6
2023-06-01
esophageal achalasia
-
2023-504263-16-00
5
2023-05-25
This is an extension study designed to provide continued treatment for
-
2022-501688-42-00
5
2023-05-24
Low Grade Glioma
-
2022-501124-23-00
5
2023-04-18
General anesthesia and sedative and anxiolytic sedation
-
2022-500085-96-00
5
2023-03-31
Patients with gambling disorder or sexual addiction or food addiction
-
2022-501494-39-00
5
2023-03-28
Uncontrolled Hypertension IN patients with moderate to severe chronic
-
2022-500520-30-00
5
2023-03-01
neurology
-
2023-507233-19-00
10
2023-02-16
Treatment of IgAN
-
2023-505065-91-00
4
2023-01-30
Advanced or Metastatic Solid Tumors including EGFR-mutated Non-Small C
-
2022-500234-29-00
5
2022-11-28
Rheumatoid Arthritis
-
2022-500197-34-01
4
2022-11-03
Megalencephaly-CApillary malformation Polymicrogyria syndrome
-
2023-508425-28-00
4
2022-10-24
Chronic Inflammatory Demyelinating Polyneuropathy
-
2022-500295-60-00
4
2022-09-15
Acute Myeloid Leukemia
-
2024-515354-24-00
9
2022-05-18
Low risk myelodysplastic syndrom without RS having failed or being ine
-
2022-502425-18-00
5
2022-04-19
Adenocarcinoma of the prostate
-
2024-511609-44-00
10
2022-02-03
Rectum cancer
-
2023-504166-37-00
4
2022-02-01
Advanced ovarian, tubal or peritoneal cancer.